openPR Logo
Press release

Prosthetic Heart Valves Market is projected to reach USD 8.84 billion by 2025 | – Edwards Lifesciences Corporation, Boston Scientific Corporation, Abbott Laboratories, St. Jude Medical, Medtronic, SYMETIS, LivaNova, CryoLife Inc.

03-18-2019 11:08 AM CET | Health & Medicine

Press release from: Research Cosmos

/ PR Agency: research cosmos
Prosthetic Heart Valves Market is projected to reach USD 8.84

Prosthetic Heart Valves Market Size and Growth Rate:
According to Our research report, the prosthetic heart valve market is projected to reach USD 8.84 Billion by 2025 from USD 4.86 Billion in 2018, at a CAGR of 12.7%.

Prosthetic Heart Valves Market Overview:
Prosthetic heart valve refers to a specific cardiac surgery that is aimed at replacing an abnormal heart valve with an artificial heart valve. The replacement of diseased valves with prosthetic heart valves reduces the morbidity and mortality associated with cardiac valve disorders.

Browse details of 117 numbers of pages research report developed on Prosthetic Heart Valves Market @ https://www.researchcosmos.com/reports/global-prosthetic-heart-valves-market-research-report-2018/64339668

Prosthetic Heart Valves Market Growth Demand and Restraints:
The prevalence of chronic heart valve-related disorders such as cardio valvular diseases, and heart failure is increasing by the day. Numerous heart disorders and arterial diseases are coming up which is driving the demand for cardiac prosthetic devices on a global level. The geriatric population suffering from heart valve disease and congenital heart defects drive the need for prosthetic cardiac devices especially. Some of the technologies for prosthetic heart valves are transcatheter valves, anti-calcification technology, and suture-less valves, polymers and carbon-based technologies. Mechanical heart valves are now used in percutaneous implantation and thoracotomy implantation as well. The overall market growth can be attributed to the rising geriatric population and the subsequent increase in the prevalence of HVD, regulatory approvals for new and advanced prosthetic heart valve, increasing government funding for heart valve research, rising awareness about HVD and favourable reimbursement scenario for prosthetic heart valve. Today, non-invasive heart valves are used in exchangeable heart valves and expandable heart valves.

There are multiple alternative options available for treating heart valve diseases such as Medication and heart valve repair. Where on the one hand, medication is used to increase the heart’s ability to pump blood, which helps compensate for the valve which is not working on the other hand, repair of heart valve can be carried out by means of open-heart surgery or minimally invasive methods. Heart valve replacement is used as a last resort usually. However, factors such as ease of implantation, increasing prevalence of aortic stenosis, and growing patient pool is helping this market boom.

Prosthetic Heart Valves Market Regional Analysis:
North America is expected to dominate the prosthetic heart valve market, followed by Europe, Asia-Pacific, and the rest of the world. The large share and high growth in this regional segment can be attributed to factors such as the rapid growth in the aging population and prevalence of valvular heart diseases, favourable reimbursement scenario, and rising product approvals for heart valve. Lack of facilities and an increased need for treatment devices have drawn key players to invest in the Middle Eastern market.

Ask Free Sample of the report @ https://www.researchcosmos.com/request/global-prosthetic-heart-valves-market-research-report-2018/64339668

Prosthetic Heart Valves Market Key Players:
Some of the leading key players are Edwards Lifesciences Corporation, Boston Scientific Corporation, Abbott Laboratories, St. Jude Medical, Medtronic, SYMETIS, LivaNova, CryoLife Inc, Braile Biomedica, Colibri Heart Valve, JenaValve Technology.

Prosthetic Heart Valves Market Segmentation:
By Product
• Mechanical Heart Valves
• Biological/Tissue Heart Valves
• Transcatheter Heart Valves

By Application
• Hospitals
• Ambulatory Surgery Centers

Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and America

For any queries, inquire more @ https://www.researchcosmos.com/inquire/global-prosthetic-heart-valves-market-research-report-2018/64339668

About Us:
Research Cosmos is a provider of standard and customized market research, business intelligence and consulting services across more than 100 domains in different industries of the world. We host the trending market reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden opportunities in every leading industry of the world

Contact:
Kevin Stewart
Global Sales Manager
Research Cosmos
www.researchcosmos.com
Blog: https://acutemarketinsights.com
Blog: https://marketreportsweb.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Prosthetic Heart Valves Market is projected to reach USD 8.84 billion by 2025 | – Edwards Lifesciences Corporation, Boston Scientific Corporation, Abbott Laboratories, St. Jude Medical, Medtronic, SYMETIS, LivaNova, CryoLife Inc. here

News-ID: 1659142 • Views:

More Releases from Research Cosmos

Mobile Phone Insurance Market Size to Reach USD 32.24 Bn By 2025
Mobile Phone Insurance Market Size to Reach USD 32.24 Bn By 2025
The size of the Global mobile phone insurance market is estimated to reach USD 32.24 billion by 2025, growing at a CAGR of 12.5%, as per the recently published report by Research Cosmos. It is worth to claim insurance for mobile phones as we are spending a lot of money on purchasing. The policies include accidental damage, water damage, and screen cracking. Browse details of the report @ https://www.researchcosmos.com/reports/mobile-phone-insurance-market/199557834 Growing utilization
Social Employee Recognition Systems Market Predicted to grow at a CAGR of xx By 2025 | Leading Market Players - Kudos, Achievers Corp., REFFIND Ltd., Globoforce, Terryberry, Ultimate Software, Peoplecart, CorporateRewards
Social Employee Recognition Systems Market Predicted to grow at a CAGR of xx By …
Social Employee Recognition Systems Market Analysis Size, Growth rate and Overview: Social Employee Recognition Systems Market was valued at USD xx million in 2018 and is expected to reach almost USD xx million by the end of 2025, growing at a CAGR of around xx% over the predicted period. Throughout the world, social employee recognition systems have expanded dramatically to address the need to move away from traditional methods and programs of

More Releases for Heart

Heart Healthy Foods and Supplements vs Heart Conditions
Heart conditions remain a major health concern worldwide, but the good news is that specific heart healthy foods and supplements can significantly improve cardiovascular health. Scientific research has demonstrated that certain foods, nutrients and supplements support heart function, reduce inflammation, and lower the risk of heart disease. Top Heart Healthy Foods Fatty Fish - Salmon, mackerel, and sardines are rich in omega-3 fatty acids, which help lower blood pressure and reduce inflammation. A
Centrifugal Heart Pumps Market | Abbott Laboratories, Abiomed, Berlin Heart, Car …
The global centrifugal heart pumps market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the centrifugal heart pumps market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth
Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH
HEART PUMP DEVICES Market 2020 | SWOT Analysis By Top Players Abbott Laboratorie …
A detailed study on HEART PUMP DEVICES Market formulated by Brandessence Market Research, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry's size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors in
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after